Sponsored by the U.S. Department of Energy Human Genome Program
Human Genome News Archive Edition
Human Genome News, July-September 1996; 8(1)
Anthony Carrano, Director of the DOE Human Genome Center at Lawrence Livermore National Laboratory (LLNL), became Vice President for the Americas of the Human Genome Organisation (HUGO) in March 1996. Grant Sutherland (Australia) is President of HUGO, which represents nearly 1000 members from 50 countries.
The three HUGO regional vice-presidents, who are also members of the 18-person International Council, serve as liaisons between their regions and the council. The Americas office representing North, South, and Central America is located in Bethesda, Maryland, and headed by Susan Wallace. The other two main offices are HUGO Europe (London), whose vice-president is Gert Jan Van Ommen, and HUGO Pacific (Osaka, Japan), for which Yoshiyuki Sakaki is the new vice-president.
Carrano is also Associate Director for Biology, Biotechnology, and Healthcare Research at LLNL. His lifelong interest is mutation research, specifically in the area of DNA repair genes; chromosome 19, which was mapped by the LLNL genome center, is particularly rich in such genes. Among the accomplishments of Carrano's research team, which is involved in numerous international collaborations, are discovery of the myotonic dystrophy gene and development of DNA research substrates for distribution to other laboratories. The group is now concentrating on sequencing chromosome 19.
The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v8n1).
The Human Genome Project (HGP) was an international 13-year effort, 1990 to 2003. Primary goals were to discover the complete set of human genes and make them accessible for further biological study, and determine the complete sequence of DNA bases in the human genome. See Timeline for more HGP history.
Published from 1989 until 2002, this newsletter facilitated HGP communication, helped prevent duplication of research effort, and informed persons interested in genome research.